Emozac?
Emozac assists in the relief of anxiety and depressive symptoms, contributes to emotional balance and promotes a positive mood. Contains Safir"Inside the only encapsulated saffron extract on the market.
assists in the relief of anxiety and depressive symptoms
contributes to emotional balance and
promotes a positive mood
Contains Safir"Inside the only encapsulated saffron extract on the market
How to use:
Take 1 capsule once daily with a meal.
Ingredients:?Each vegetarian capsule contains:
Active ingredients: Per capsule: Crocus sativus L. (Safr?InsideTM Saffron stigma extract) 30 mg Inactive ingredients: Magnesium stearate (vegetable grade) and tapioca starch. Halaal, sugar free, vegetarian and vegan friendly.
Empa-Q 10mg Tablets 20`s is a prescription medication that belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors. It treats adults with type 2 diabetes to improve blood sugar control. Empagliflozin works by increasing the amount of sugar that is removed from the body through the urine.
Empagliflozin is taken by mouth, usually once a day. The recommended dose is 25 mg once daily. Still, the dose may be adjusted based on the individual?s blood sugar levels and response to treatment. It is vital to take empagliflozin precisely as prescribed by a healthcare provider. The medication should be taken simultaneously daily to maintain a consistent level in the body.
Empagliflozin may cause side effects, including urinary tract infections, genital infections, and increased urination. It may also increase the risk of dehydration and low blood pressure. Notifying a healthcare provider if these or any other side effects occur is important. Empagliflozin may also interact with other medications, so it is important to tell a healthcare provider about all the medicines being taken.
Empagliflozin is a prescription medication and should be taken only under the direction of a healthcare provider. It is important to follow the prescribed dosing and not stop taking the medication without consulting a healthcare provider.
Empa-Q 25mg Tablets 20`s is a prescription medication that belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors. It treats adults with type 2 diabetes to improve blood sugar control. Empagliflozin works by increasing the amount of sugar that is removed from the body through the urine.
Empagliflozin is taken by mouth, usually once a day. The recommended dose is 25 mg once daily. Still, the dose may be adjusted based on the individual?s blood sugar levels and response to treatment. It is vital to take empagliflozin precisely as prescribed by a healthcare provider. The medication should be taken simultaneously daily to maintain a consistent level in the body.
Empagliflozin may cause side effects, including urinary tract infections, genital infections, and increased urination. It may also increase the risk of dehydration and low blood pressure. Notifying a healthcare provider if these or any other side effects occur is important. Empagliflozin may also interact with other medications, so it is important to tell a healthcare provider about all the medicines being taken.
Empagliflozin is a prescription medication and should be taken only under the direction of a healthcare provider. It is important to follow the prescribed dosing and not stop taking the medication without consulting a healthcare provider.
Empaa Tablets SpecificationRequires Prescription (YES/NO)YesGenericsEmpagliflozinUsed ForDiabetesHow it worksSodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.Empaa Tablets Usage And SafetyDosageEmpagliflozinSide EffectsVery Common : Hypoglycemia (when used with sulphonylurea or insulin).Common : Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection, urinary tract infection, pruritus (generalised) and increased urination.Uncommon : Volume depletion, dysuria and blood creatinine increased / glomerular filtration rate decreased.Rare : Diabetic ketoacidosisDrug InteractionsDiuretics , thiazide and loop diuretics , SGLT2 inhibitorsIndicationEmpagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:Monotherapy : When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance.Add-on combination therapy : In combination with other glucose?lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control. When not to UseEmpagliflozin is contraindicated in:? Patients with known hypersensitivity to empagliflozin or to any excipient of the product.? Severe renal impairment, end-stage renal disease or dialysis.Empaa Tablets PrecautionsPrecautionEmpagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic bloodpressure and in patients on diuretics.Empaa Tablets WarningsWarning 1Insulin and insulin secretagogues are known to cause hypoglycemia. The risk of hypoglycemia is increased when empagliflozin is used in combination with insulin secretagogues (e.g., sulphonylurea) or insulin.Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with empagliflozin.Warning 2Empagliflozin increases the risk for urinary tract infections including urosepsis and pyelonephritis requiring hospitalisation in patients receiving SGLT2 inhibitors, including empagliflozin. Monitor and treat asappropriate. Discontinuation of empagliflozin may be considered in cases of recurrent urinary tract infections.Warning 3Empagliflozin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (DKA). In patients where DKA is suspected or diagnosed, treatment with empagliflozin should bediscontinued immediately. Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised. Empaa Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
AB FLO SR 200MG TABLET ₦4,916.00
Kin Fresh Toothpaste 125ml ₦10,500.00
Dewsoft Premia Lotion (50ml) ₦8,500.00
?Emoline Moisturizing Emollient 80gm Product Form: Emolient Pack Size: 80gm
?Emoly Emolleint 100g
Empaa Tablets SpecificationRequires Prescription (YES/NO)YesGenericsEmpagliflozinUsed ForDiabetesHow it worksSodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.Empaa Tablets Usage And SafetyDosageEmpagliflozinSide EffectsVery Common : Hypoglycemia (when used with sulphonylurea or insulin).Common : Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection, urinary tract infection, pruritus (generalised) and increased urination.Uncommon : Volume depletion, dysuria and blood creatinine increased / glomerular filtration rate decreased.Rare : Diabetic ketoacidosisDrug InteractionsDiuretics , thiazide and loop diuretics , SGLT2 inhibitorsIndicationEmpagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:Monotherapy : When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance.Add-on combination therapy : In combination with other glucose?lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control. When not to UseEmpagliflozin is contraindicated in:? Patients with known hypersensitivity to empagliflozin or to any excipient of the product.? Severe renal impairment, end-stage renal disease or dialysis.Empaa Tablets PrecautionsPrecautionEmpagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic bloodpressure and in patients on diuretics.Empaa Tablets WarningsWarning 1Insulin and insulin secretagogues are known to cause hypoglycemia. The risk of hypoglycemia is increased when empagliflozin is used in combination with insulin secretagogues (e.g., sulphonylurea) or insulin.Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with empagliflozin.Warning 2Empagliflozin increases the risk for urinary tract infections including urosepsis and pyelonephritis requiring hospitalisation in patients receiving SGLT2 inhibitors, including empagliflozin. Monitor and treat asappropriate. Discontinuation of empagliflozin may be considered in cases of recurrent urinary tract infections.Warning 3Empagliflozin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (DKA). In patients where DKA is suspected or diagnosed, treatment with empagliflozin should bediscontinued immediately. Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised. Empaa Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.